Tokyo, Japan

Kiyofumi Ishikawa

This inventor holds 17 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1984-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyofumi Ishikawa. Retrieved from https://idiyas.com/inventor/kiyofumi-ishikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 204(Granted Patents)


Location History:

  • Chofu, JP (1984 - 1994)
  • Meguro, JP (1994)
  • Tsukuba, JP (1995 - 1996)
  • Tokyo, JP (1992 - 1997)
  • Menuma-machi, JP (1998)
  • Saitama, JP (2000)

Company Filing History:


Years Active: 1984-2000

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Kiyofumi Ishikawa: Innovator in Pharmaceutical Chemistry

Introduction

Kiyofumi Ishikawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 17 patents. His work focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the "Process for producing halogenated heteroaryl compounds" and "Endothelin antagonistic heteroaromatic ring-fused cyclopentene." These inventions reflect his expertise in creating complex chemical structures that can lead to new medical treatments.

Career Highlights

Kiyofumi Ishikawa is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to push the boundaries of pharmaceutical research. His career is marked by a commitment to advancing drug development through innovative chemical processes.

Collaborations

He has collaborated with notable colleagues such as Mitsuo Yano and Takashi Hayama, contributing to a dynamic research environment that fosters creativity and innovation.

Conclusion

Kiyofumi Ishikawa's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…